These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17515450)

  • 1. Role of matrix metalloproteinases in early hypertensive vascular remodeling.
    Flamant M; Placier S; Dubroca C; Esposito B; Lopes I; Chatziantoniou C; Tedgui A; Dussaule JC; Lehoux S
    Hypertension; 2007 Jul; 50(1):212-8. PubMed ID: 17515450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMP3 is the primary TIMP to regulate agonist-induced vascular remodelling and hypertension.
    Basu R; Lee J; Morton JS; Takawale A; Fan D; Kandalam V; Wang X; Davidge ST; Kassiri Z
    Cardiovasc Res; 2013 Jun; 98(3):360-71. PubMed ID: 23524300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling.
    Lehoux S; Lemarié CA; Esposito B; Lijnen HR; Tedgui A
    Circulation; 2004 Mar; 109(8):1041-7. PubMed ID: 14967734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice.
    Pushpakumar S; Kundu S; Pryor T; Givvimani S; Lederer E; Tyagi SC; Sen U
    J Hypertens; 2013 Nov; 31(11):2270-81; discussion 2281. PubMed ID: 24077247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats.
    Wang M; Zhang J; Spinetti G; Jiang LQ; Monticone R; Zhao D; Cheng L; Krawczyk M; Talan M; Pintus G; Lakatta EG
    Am J Pathol; 2005 Nov; 167(5):1429-42. PubMed ID: 16251426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in the pressor and tubuloglomerular feedback response to angiotensin II.
    Brown RD; Hilliard LM; Head GA; Jones ES; Widdop RE; Denton KM
    Hypertension; 2012 Jan; 59(1):129-35. PubMed ID: 22124434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
    Brassard P; Amiri F; Schiffrin EL
    Hypertension; 2005 Sep; 46(3):598-606. PubMed ID: 16043661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
    Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
    Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration.
    Endtmann C; Ebrahimian T; Czech T; Arfa O; Laufs U; Fritz M; Wassmann K; Werner N; Petoumenos V; Nickenig G; Wassmann S
    Hypertension; 2011 Sep; 58(3):394-403. PubMed ID: 21825227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lysyl oxidase inhibition on angiotensin II-induced arterial hypertension, remodeling, and stiffness.
    Eberson LS; Sanchez PA; Majeed BA; Tawinwung S; Secomb TW; Larson DF
    PLoS One; 2015; 10(4):e0124013. PubMed ID: 25875748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated responses to angiotensin II in follitropin receptor knockout mice, a model of menopause-associated hypertension.
    Javeshghani D; Touyz RM; Sairam MR; Virdis A; Neves MF; Schiffrin EL
    Hypertension; 2003 Oct; 42(4):761-7. PubMed ID: 12885794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during Angiotensin II induced aneurysm formation.
    Eagleton MJ; Ballard N; Lynch E; Srivastava SD; Upchurch GR; Stanley JC
    J Surg Res; 2006 Oct; 135(2):345-51. PubMed ID: 16716358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
    Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
    J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme oxygenase-1 induction does not improve vascular relaxation in angiotensin II hypertensive mice.
    Stec DE; Vera T; McLemore GR; Kelsen S; Rimoldi JM; Gadepalli RS; Ryan MJ
    Am J Hypertens; 2008 Feb; 21(2):189-93. PubMed ID: 18174886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II.
    Matsui R; Xu S; Maitland KA; Hayes A; Leopold JA; Handy DE; Loscalzo J; Cohen RA
    Circulation; 2005 Jul; 112(2):257-63. PubMed ID: 15998684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of extracellular superoxide dismutase in hypertension.
    Gongora MC; Qin Z; Laude K; Kim HW; McCann L; Folz JR; Dikalov S; Fukai T; Harrison DG
    Hypertension; 2006 Sep; 48(3):473-81. PubMed ID: 16864745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
    Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
    Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension.
    Potthoff SA; Stamer S; Grave K; Königshausen E; Sivritas SH; Thieme M; Mori Y; Woznowski M; Rump LC; Stegbauer J
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27407119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling.
    Ikeda Y; Aihara K; Yoshida S; Sato T; Yagi S; Iwase T; Sumitomo Y; Ise T; Ishikawa K; Azuma H; Akaike M; Kato S; Matsumoto T
    Endocrinology; 2009 Jun; 150(6):2857-64. PubMed ID: 19196803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
    J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.